Select Page

LifeBond closes $27 million Series D Round LifeBond, a leader in the development of bio-surgical medical devices for tissue repair, announced has closed a $27M Series D preferred equity investment. Participants in the round include Pitango Venture Capital, Adams Street Partners, Sino Biopharmaceutical Ltd., and all existing investors. “LifeSeal is a novel product that addresses an urgent unmet need that industry has not been able to solve for, until now. The product has the potential to greatly reduce surgical leaks, which are associated with potential infections and other serious complications, risking the lives of hundreds of thousands every year,” said Ittai Harel, chairman of LifeBond and a general partner at Pitango. VideoStir Spokesperson plugin raises $777,000 in Seed round Tel Aviv-based VideoStir supplies an end-to-end automatic on-line service that allows anyone with a simple video camera to transform a standard amateur video recording into a sophisticated professional-looking “floating” clip that can be instantly embedded onto any website. VideoStir allows you to create and add a free virtual spokesperson to any website in minutes! VideoStir advanced patent pending technology automatically removes your video’s background without the need for a green screen. [youtube] Predictive analytics platform Leadspace raises $18 million Series B round Leadspace raises $18 million round led by Battery Ventures, with participation of existing investors Jerusalem Venture Partners (JVP) and Vertex VC. Leadspace is a SaaS-based predictive analytics platform helping B2B marketing and sales professionals discover, enrich and score leads for improved revenue. With the click of a button within Salesforce, Leadspace finds you highly-targeted prospects using the fingerprints they leave in social networks and on the Web. MEDX raises $30 million for biomed investment fund MEDX Ventures Group, led by CEO Harel Gadot, announced that it raised $30 million from private investors, to fund seed and pre-seed biomedical startups. Catheter developer Eximo Medical raises $1.6 million Series A Eximo Medical has completed its Series A funding round of $1.6M. Accelmed, a leading medical device Investment Fund, led the round, with the participation of the Alfred Mann Institute at the Technion (AMIT), the Technion R&D Foundation Ltd. and a private investor. Founded in 2012, Eximo is dedicated to developing safe and efficient transluminal solutions for interventional vascular and gastrointestinal procedures. The company’s Cathi™ catheters are based on innovative technology comprising a proprietary hybrid laser and “blunt” blade components and a compact laser system with a tiny footprint.]]>